Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board
Vivacitas Oncology, Inc. (“Vivacitas” or the “Company”), a privately held oncology company focused on tough-to-treat cancers, is pleased to announce that Dr. Jai Grewal, MD, has agreed to become a new member of their distinguished Neuro-Oncology Advisory Board. Dr. Grewal will be joining Dr. Andrew Lassman, MD, MS, FAAN in the company’s Scientific Advisory Board. Dr. Jai … Read more